These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 950175)

  • 1. Further studies of the interaction between ristocetin and fibrinogen.
    Goh AT; Firkin BG
    Haemostasis; 1976; 5(2):57-65. PubMed ID: 950175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of Haemaccel, fibrinogen and albumin on ristocetin-induced platelet aggregation. Relevance to the quantitative measurement of the ristocetin cofactor.
    Stibbe J; Kirby EP
    Thromb Res; 1976 Feb; 8(2):151-65. PubMed ID: 1251347
    [No Abstract]   [Full Text] [Related]  

  • 3. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand's syndrome. Studies on a variant factor VIII.
    Hill FG; Chan MC; Hardisty RM
    Haemostasis; 1976; 5(5):276-84. PubMed ID: 797643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma components which interfere with ristocetin-induced platelet aggregation.
    Baugh RF; Brown JE; Hougie C
    Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin.
    Coller BS; Gralnick HR
    J Clin Invest; 1977 Aug; 60(2):302-12. PubMed ID: 17620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precipitation of fibrin monomers and fibrin degradation products by ristocetin.
    Watanabe K; Tullis JL
    Am J Med Sci; 1978; 275(3):337-44. PubMed ID: 80134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some factors affecting fibrinogen precipitation by ristocetin: ultrastructure of precipitates.
    Ts'ao C; Green D; Rossi EC
    Blood; 1975 May; 45(5):621-9. PubMed ID: 1120188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.
    Girolami A; Fabris F; Marco L; Peruffo R
    Acta Haematol; 1976; 56(3):151-9. PubMed ID: 826070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K; Kubonishi I; Taguchi H; Miyoshi I
    Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
    Coller BS
    J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vancomycin on platelets, plasma proteins and hepatitis B surface antigen.
    Coller BS; Lundberg WB; Gralnick HR
    Thromb Diath Haemorrh; 1975 Sep; 34(1):83-93. PubMed ID: 1188837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.